Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of PEN 1.01 trillion. The enterprise value is 1.13 trillion.

Market Cap	1.01T
Enterprise Value	1.13T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Dec 15, 2025

Share Statistics

Current Share Class	2.47B
Shares Outstanding	n/a
Shares Change (YoY)	-1.34%
Shares Change (QoQ)	-0.40%
Owned by Insiders (%)	0.05%
Owned by Institutions (%)	79.98%
Float	2.47B

Valuation Ratios

The trailing PE ratio is 16.44 and the forward PE ratio is 23.63.

PE Ratio	16.44
Forward PE	23.63
PS Ratio	4.62
PB Ratio	5.70
P/TBV Ratio	69.06
P/FCF Ratio	24.28
P/OCF Ratio	18.22
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.39, with an EV/FCF ratio of 27.20.

EV / Earnings	18.42
EV / Sales	5.17
EV / EBITDA	11.39
EV / EBIT	13.74
EV / FCF	27.20

Financial Position

The company has a current ratio of 1.54, with a Debt / Equity ratio of 0.96.

Current Ratio	1.54
Quick Ratio	0.96
Debt / Equity	0.96
Debt / EBITDA	1.71
Debt / FCF	4.09
Interest Coverage	18.03

Financial Efficiency

Return on equity (ROE) is 36.88% and return on invested capital (ROIC) is 25.91%.

Return on Equity (ROE)	36.88%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	25.91%
Return on Capital Employed (ROCE)	22.54%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	2.96M
Profits Per Employee	829,866
Employee Count	75,000
Asset Turnover	0.51
Inventory Turnover	2.32

Taxes

In the past 12 months, Merck & Co. has paid 9.43 billion in taxes.

Income Tax	9.43B
Effective Tax Rate	13.31%

Stock Price Statistics

The stock price has increased by +34.54% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+34.54%
50-Day Moving Average	112.45
200-Day Moving Average	92.17
Relative Strength Index (RSI)	73.56
Average Volume (20 Days)	53

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.10

Income Statement

In the last 12 months, Merck & Co. had revenue of PEN 218.71 billion and earned 61.41 billion in profits. Earnings per share was 24.49.

Revenue	218.71B
Gross Profit	168.87B
Operating Income	82.31B
Pretax Income	70.87B
Net Income	61.41B
EBITDA	97.92B
EBIT	82.31B
Earnings Per Share (EPS)	24.49

Full Income Statement

Balance Sheet

The company has 49.00 billion in cash and 170.01 billion in debt, giving a net cash position of -121.01 billion.

Cash & Cash Equivalents	49.00B
Total Debt	170.01B
Net Cash	-121.01B
Net Cash Per Share	n/a
Equity (Book Value)	177.17B
Book Value Per Share	71.52
Working Capital	51.10B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 55.42 billion and capital expenditures -13.83 billion, giving a free cash flow of 41.58 billion.

Operating Cash Flow	55.42B
Capital Expenditures	-13.83B
Free Cash Flow	41.58B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 77.21%, with operating and profit margins of 37.64% and 28.08%.

Gross Margin	77.21%
Operating Margin	37.64%
Pretax Margin	32.41%
Profit Margin	28.08%
EBITDA Margin	44.77%
EBIT Margin	37.64%
FCF Margin	19.01%

Dividends & Yields

This stock pays an annual dividend of 11.57, which amounts to a dividend yield of 9.64%.

Dividend Per Share	11.57
Dividend Yield	9.64%
Dividend Growth (YoY)	-0.89%
Years of Dividend Growth	n/a
Payout Ratio	44.79%
Buyback Yield	1.34%
Shareholder Yield	10.97%
Earnings Yield	6.08%
FCF Yield	4.12%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.

Altman Z-Score	3.5
Piotroski F-Score	5